Our Commitment to FDA Compliance
Bluetail Medical Group is committed to providing regenerative medicine treatments that comply with all applicable FDA regulations. Our physicians stay current with evolving regulatory frameworks and ensure that all procedures are performed within established guidelines.
We use only FDA-cleared devices for the preparation of autologous biologic therapies, including platelet-rich plasma (PRP) and bone marrow aspirate concentrate (BMAC). All products used in our treatments are derived from the patient's own body (autologous) and are prepared at the point of care.
FDA IDE Approved Research
Bluetail Medical Group has received FDA Investigational Device Exemption (IDE) approval for a pivotal study of the use of cellular therapy in the treatment of knee osteoarthritis. This landmark approval demonstrates our commitment to advancing regenerative medicine through rigorous clinical research conducted under FDA oversight.
Regulatory Standards
Our practice adheres to the following regulatory standards:
- Preparations are performed using FDA-cleared devices
- Procedures are performed at the point of care by licensed physicians
- Our physicians participate in ongoing education regarding regulatory compliance
- We maintain detailed records of all procedures and outcomes
Evidence-Based, FDA-Compliant Care
Trust your treatment to physicians who prioritize both innovation and regulatory compliance.